Literature DB >> 34859118

High-throughput 3D Spheroid Formation and Effective Cardiomyocyte Differentiation from Human iPS Cells Using the Microfabric Vessels EZSPHERETM.

Tatsuaki Miwa1, Alimjan Idiris2, Hiromichi Kumagai3.   

Abstract

High-throughput 3D spheroid formation from human induced pluripotent stem cells (hiPSCs) can be easily performed using the unique microfabric vessels EZSPHERE, resulting in effective and large scale generation of differentiated cells such as cardiomyocytes or neurons. Such hiPSC-derived cardiomyocytes (hiPSC-CMs) or neurons are very useful in the fields of regenerative medicine or cell-based drug safety tests. Previous studies indicated that 3D spheroids arising from hiPSCs are effectively differentiated into high quality hiPSC-CMs by controlling Wnt signals through utilization of the microfabric vessels EZSPHERE. Here, we describe a simple and highly efficient protocol for generating a large number of uniformly sized hiPSC spheroids and inducing them for cardiac differentiation using the EZSPHERE. This method comprises the collection and dissociation of the spheroids from cardiac differentiation medium, in the middle stage of the whole cardiac differentiation process, and re-seeding the obtained single cells into the EZSPHERE to re-aggregate them into uniform hiPSC-CM spheroids with controlled size. This re-aggregation process promotes non-canonical Wnt signal-related cardiac development and improves the purity and maturity of the hiPSC-CMs generated. Graphic abstract: Overview of cardiac differentiation from iPSCs by spheroid formation and reaggregation using EZSPHERE.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  3D spheroids; Cardiomyocyte differentiation; Cell aggregates; Drug safety test; EZSPHERE; Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs); Human induced pluripotent stem cells (hiPSCs); Microfabric vessels; Regenerative medicine; Spheroid re-aggregation

Year:  2021        PMID: 34859118      PMCID: PMC8595437          DOI: 10.21769/BioProtoc.4203

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  16 in total

1.  Wnt5a and Wnt11 are essential for second heart field progenitor development.

Authors:  Ethan David Cohen; Mayumi F Miller; Zichao Wang; Randall T Moon; Edward E Morrisey
Journal:  Development       Date:  2012-06       Impact factor: 6.868

2.  Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11.

Authors:  Yu-Shik Hwang; Bong Geun Chung; Daniel Ortmann; Nobuaki Hattori; Hannes-Christian Moeller; Ali Khademhosseini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

3.  Enrichment of cardiac differentiation by a large starting number of embryonic stem cells in embryoid bodies is mediated by the Wnt11-JNK pathway.

Authors:  Ming Chen; Cheng Qian; Lin-Lin Bi; Fang Zhao; Guang-Yu Zhang; Zhi-Quan Wang; Xue-Dong Gan; Yang-Gan Wang
Journal:  Biotechnol Lett       Date:  2014-10-14       Impact factor: 2.461

4.  Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias.

Authors:  Ksenia Blinova; Jayna Stohlman; Jose Vicente; Dulciana Chan; Lars Johannesen; Maria P Hortigon-Vinagre; Victor Zamora; Godfrey Smith; William J Crumb; Li Pang; Beverly Lyn-Cook; James Ross; Mathew Brock; Stacie Chvatal; Daniel Millard; Loriano Galeotti; Norman Stockbridge; David G Strauss
Journal:  Toxicol Sci       Date:  2016-10-03       Impact factor: 4.849

5.  Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.

Authors:  Yuji Shiba; Toshihito Gomibuchi; Tatsuichiro Seto; Yuko Wada; Hajime Ichimura; Yuki Tanaka; Tatsuki Ogasawara; Kenji Okada; Naoko Shiba; Kengo Sakamoto; Daisuke Ido; Takashi Shiina; Masamichi Ohkura; Junichi Nakai; Narumi Uno; Yasuhiro Kazuki; Mitsuo Oshimura; Itsunari Minami; Uichi Ikeda
Journal:  Nature       Date:  2016-10-10       Impact factor: 49.962

6.  Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Daiju Yamazaki; Takashi Kitaguchi; Masakazu Ishimura; Tomohiko Taniguchi; Atsuhiro Yamanishi; Daisuke Saji; Etsushi Takahashi; Masao Oguchi; Yuta Moriyama; Sanae Maeda; Kaori Miyamoto; Kaoru Morimura; Hiroki Ohnaka; Hiroyuki Tashibu; Yuko Sekino; Norimasa Miyamoto; Yasunari Kanda
Journal:  J Pharmacol Sci       Date:  2018-03-03       Impact factor: 3.337

7.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population.

Authors:  Lei Yang; Mark H Soonpaa; Eric D Adler; Torsten K Roepke; Steven J Kattman; Marion Kennedy; Els Henckaerts; Kristina Bonham; Geoffrey W Abbott; R Michael Linden; Loren J Field; Gordon M Keller
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

8.  Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture.

Authors:  Henning Kempf; Ruth Olmer; Christina Kropp; Michael Rückert; Monica Jara-Avaca; Diana Robles-Diaz; Annika Franke; David A Elliott; Daniel Wojciechowski; Martin Fischer; Angelica Roa Lara; George Kensah; Ina Gruh; Axel Haverich; Ulrich Martin; Robert Zweigerdt
Journal:  Stem Cell Reports       Date:  2014-10-30       Impact factor: 7.765

9.  hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.

Authors:  André Monteiro da Rocha; Katherine Campbell; Sergey Mironov; Jiang Jiang; Lakshmi Mundada; Guadalupe Guerrero-Serna; José Jalife; Todd J Herron
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

10.  Microfabric Vessels for Embryoid Body Formation and Rapid Differentiation of Pluripotent Stem Cells.

Authors:  Hiroki Sato; Alimjan Idiris; Tatsuaki Miwa; Hiromichi Kumagai
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.